APA

Chanez P., Contin-Bordes C., Garcia G., Verkindre C., Didier A., De Blay F., de Lara M. T., Blanco P., Moreau J., Robinson P., Bourdeix I., Trunet P., Le Gros V., Humbert M. & Molimard M. (20110222). Omalizumab-induced decrease of FcξRI expression in patients with severe allergic asthma. : Respiratory medicine.

Chicago

Chanez Pascal, Contin-Bordes Cécile, Garcia Gilles, Verkindre Christophe, Didier Alain, De Blay Frédéric, de Lara Manuel Tunon, Blanco Patrick, Moreau Jean-François, Robinson Philip, Bourdeix Isabelle, Trunet Patrick, Le Gros Vincent, Humbert Marc and Molimard Mathieu. 20110222. Omalizumab-induced decrease of FcξRI expression in patients with severe allergic asthma. : Respiratory medicine.

Harvard

Chanez P., Contin-Bordes C., Garcia G., Verkindre C., Didier A., De Blay F., de Lara M. T., Blanco P., Moreau J., Robinson P., Bourdeix I., Trunet P., Le Gros V., Humbert M. and Molimard M. (20110222). Omalizumab-induced decrease of FcξRI expression in patients with severe allergic asthma. : Respiratory medicine.

MLA

Chanez Pascal, Contin-Bordes Cécile, Garcia Gilles, Verkindre Christophe, Didier Alain, De Blay Frédéric, de Lara Manuel Tunon, Blanco Patrick, Moreau Jean-François, Robinson Philip, Bourdeix Isabelle, Trunet Patrick, Le Gros Vincent, Humbert Marc and Molimard Mathieu. Omalizumab-induced decrease of FcξRI expression in patients with severe allergic asthma. : Respiratory medicine. 20110222.